Pharmacologic management of neuropathic pain: Evidence-based recommendations
- R. Dworkin, Alec B. O’Connor, M. Backonja, J. Farrar, M. Wallace
- Medicine, PsychologyPain
- 1 December 2007
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations.
- R. Dworkin, M. Backonja, S. Weinstein
- Medicine, PsychologyArchives of Neurology
- 1 November 2003
Randomized controlled clinical trials of gabapentin, the 5% lidocaine patch, opioid analgesics, tramadol hydrochloride, and tricyclic antidepressants provide an evidence-based approach to the treatment of neuropathic pain.
Recommendations for the management of herpes zoster.
- R. Dworkin, Robert W. Johnson, R. Whitley
- Medicine, PsychologyClinical Infectious Diseases
- 2007
The results of controlled trials and the clinical experience of the authors support the use of acyclovir, brivudin (where available), famciclovir, and valacy Clovir as first-line antiviral therapy for the treatment of patients with HZ.
NeuPSIG guidelines on neuropathic pain assessment
- M. Haanpää, N. Attal, R. Treede
- Medicine, PsychologyPain
- 1 January 2011
External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria
- S. Bruehl, R. Harden, M. Stanton‐Hicks
- Medicine, PsychologyPain
- 1 May 1999
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study
- M. Backonja, M. Wallace, J. Tobias
- Medicine, PsychologyLancet Neurology
- 1 December 2008
Using screening tools to identify neuropathic pain
- M. Bennett, N. Attal, T. Jensen
- MedicinePain
- 1 February 2007
Value of quantitative sensory testing in neurological and pain disorders: NeuPSIG consensus
- M. Backonja, N. Attal, D. Ziegler
- Medicine, PsychologyPain
- 1 September 2013
A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.
- G. Irving, M. Backonja, J. Tobias
- MedicinePain medicine (Malden, Mass.)
- 2011
In patients with PHN, a single 60-minute application of NGX-4010 produced significant reduction in pain that was maintained over a 12-week period.
Evidence-based guideline: Treatment of painful diabetic neuropathy
- V. Bril, J. England, D. Zochodne
- Medicine, PsychologyNeurology
- 11 April 2011
A systematic review of the literature from 1960 to August 2008 found effective treatments for PDN are available, but many have side effects that limit their usefulness, and few studies have sufficient information on treatment effects on function and QOL.
...
...